Haloperidol increases spreading and nitric oxide production in macrophages from tumor-bearing mice: A possible mechanism for its antitumoral effect

International Journal of Immunopharmacology

Volumn 21, Issue 9, 1999, Pages 575-580

  Kleeb, Silvia R ^a   Rizzo, Márcia Dos S ^a   Dagli, Maria L Z ^a   Frussa Filho, Roberto ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ehrlich adenocarcinoma; Haloperidol; Macrophage; Nitric oxide

Indexed keywords

AMINOGUANIDINE; HALOPERIDOL; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; EHRLICH ASCITES TUMOR; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; ENZYME INHIBITORS; GUANIDINES; HALOPERIDOL; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; NEOPLASM TRANSPLANTATION; NITRIC OXIDE;

EID: 0032841023     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00036-3     Document Type: Article

References (19)

1. Shavit Y., Terman G.W., Martin F.C., Lewis J.W., Liebeskind J.C., Gale R.P. Stress, opioid peptides, the immune system, and cancer. The J. Immunol. 135:1985;834-837.
2. Sarro G.B., Masuda Y., Ascioti C., Audino M.G., Nistiro G. Behavioral and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone. Neuropharmacology. 29:1990;167-179.
3. Jankovié B.D. Neuroimmunomodulation: facts and dilemmas. Immunol. Letters. 21:1989;101-118.
4. Wang J.K.T., Morgan J.I., Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc. Natl. Acad. Sci. USA. 81:1984;753-756.
5. McLaughlin P.J., Zagon I.S. Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems. Life Sci. 41:1987;1465-1472.
6. Frussa-Filho R., Soares C.G.C., Décio R.C., Franchischetti I., Haber V.A., Onimaru A.T. Antitumor effects of dopaminergic blockers in mice bearing Ehrlich tumors. Brazilian J. Med. Biol. Res. 24:1991;611-614.
7. Frussa-Filho R., Monteiro M.C., Soares C.G.S., Décio R.C. Effects of haloperidol, bromocriptine and amphetamine on the development of Ehrlich ascites carcinoma in mice. Pharmacology. 45:1992;58-60.
8. Kleeb S.R., Xavier J.G., Frussa-Filho R., Dagli M.L.Z. Effect of haloperidol on the development of the solid Ehrlich tumor in mice. Life Sci. 60:1997;69-74.
9. Hibbs J.B., Vavrin Z., Taintor R.R. L-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. The J. Immunol. 138:1987;550-565.
10. Keller R., Keist R., Wesclsler A., Leist T.P., Van Der Meide P.H. Mechanisms of macrophage-mediated tumor cell killing: a comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factor. Int. J. Cancer. 46:1990;682.
11. Yim C.Y., Bastian N.R., Smith J.C., Hibbs J.B. Jr, Samlowski W.E. Macrophage nitric-oxide synthesis delays progression of ultraviolet-light-induced murine skin cancer. Cancer Res. 53:1993;5507-5511.
12. DiNapoli M.R., Calderon C.L., Lopez D.M. Phosphatidyl serine is involved in the reduced rate of transcription of the inducible nitric oxide synthase gene in macrophages from tumor-bearing mice. The J. Immunol. 158:1997;1810-1817.
13. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. The Am. Soc. Pharmacol. Exp. Ther. 43:1991;109-142.
14. Misko T.P., Moore W.M., Kasten T.P., Nickols G.A., Corbett J.A., Tilton R.G., McDaniel M.L., Williamson J.R., Currie M.G. Selective inhibition of the inducible nitric oxide syntase by aminoguanidine. Eur. J. Pharmacol. 233:1993;119-125.
15. Rabinovitch M., Manejias R.E., Russo M., Abbey E.E. Increased spreading of macrophages from mice treated with interferons inducers. Cell Immunol. 29:1977;86-95.
16. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. The J. Immunol. 141:1988;2407-2412.
17. Besser G.M., Delitala G., Grossman A., Stubs W.A., Yeo T. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations. British J. Pharmacol. 71:1980;569-573.
18. ++ and protein kinase C. Int. J. Immunopharmacol. 19:1997;129-133.
19. Bernton E.W., Meltzer M.S., Holaday J.W. Suppression of macrophage activation and t-lymphocyte function in hipoprolactinemic mice. Science. 239:1988;401-404.